NOVO.B.DK

281.65

-0.09%↓

COLO.B.DK

376.3

-2.13%↓

HLUNB.DK

44.78

+0.63%↑

ZEAL.DK

292.8

+3.46%↑

AMBUB.DK

62.9

-1.8%↓

NOVO.B.DK

281.65

-0.09%↓

COLO.B.DK

376.3

-2.13%↓

HLUNB.DK

44.78

+0.63%↑

ZEAL.DK

292.8

+3.46%↑

AMBUB.DK

62.9

-1.8%↓

NOVO.B.DK

281.65

-0.09%↓

COLO.B.DK

376.3

-2.13%↓

HLUNB.DK

44.78

+0.63%↑

ZEAL.DK

292.8

+3.46%↑

AMBUB.DK

62.9

-1.8%↓

NOVO.B.DK

281.65

-0.09%↓

COLO.B.DK

376.3

-2.13%↓

HLUNB.DK

44.78

+0.63%↑

ZEAL.DK

292.8

+3.46%↑

AMBUB.DK

62.9

-1.8%↓

NOVO.B.DK

281.65

-0.09%↓

COLO.B.DK

376.3

-2.13%↓

HLUNB.DK

44.78

+0.63%↑

ZEAL.DK

292.8

+3.46%↑

AMBUB.DK

62.9

-1.8%↓

Home・Listă Acțiuni・Genmab A-S

Genmab A-S

Închisă

1,620 0.34

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

1580.5

Maxim

1628.5

Indicatori cheie
By Trading Economics
Venit	21M 52M
Vânzări	-184M 881M
P/E Medie Sector	18.691 49.052
EPS	8.48
Marjă de profit	5.915
Angajați	3,088
EBITDA	-23M 221M

Recomandări
By TipRanks
Recomandări	Neutru
Prognoză pe 12 luni	-1.49% downside

Dividende
By Acuity
Următoarele câștiguri	6 aug. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	-7.6B 97B
Deschiderea anterioară	1619.66
Închiderea anterioară	1620

Genmab A-S Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

10 iun. 2026, 23:56 UTC

Macro News

ETF Constituents

Correlated Moves

The iShares Global Infrastructure ETF is lower in after-market hours, influenced by declines in the Canadian market and rising geopolitical tensions.

10 iun. 2026, 23:56 UTC

JD.Com Inc. is trading roughly flat in after-market hours, with performance reflecting a position about 6.33% below its 20-day moving average.

10 iun. 2026, 23:56 UTC

Cisco Systems shares are lower in after-market trading, continuing a trend of three consecutive sessions finishing down. No specific news was identified for the decline.

10 iun. 2026, 23:53 UTC

News

Correlated Moves

Silver/GBP declines amid geopolitical tensions in Iran and rising U.S. inflation, breaking a recent trend of higher daily closes. Gold also trades lower.

10 iun. 2026, 23:52 UTC

News

Correlated Moves

SPDR Gold Shares are trading lower after reports of explosions in Tehran raise regional stability concerns, prompting investors to seek safe-haven assets.

10 iun. 2026, 23:52 UTC

News

Correlated Moves

Silver/JPY is trading lower as geopolitical tensions in Iran affect investor sentiment and contribute to fluctuations in precious metals. Gold's decline also impacts silver prices.

10 iun. 2026, 23:52 UTC

News

Correlated Moves

Silver prices are lower amid geopolitical tensions in Iran and rising U.S. inflation, breaking a recent trend of higher daily closes.

10 iun. 2026, 23:52 UTC

News

Correlated Moves

Silver/CAD declines amid geopolitical tensions in Iran and rising U.S. inflation, reversing a trend of higher daily closes. Gold also trades lower in correlation.

10 iun. 2026, 23:52 UTC

News

Correlated Moves

Silver declines amid geopolitical tensions in Iran and rising U.S. inflation, breaking a recent trend of higher daily closes. Gold also shows a downward movement.

10 iun. 2026, 23:51 UTC

Amgen Inc. shares declined in after-market trading, continuing a trend of lower daily closes amid rising Treasury yields and weakness in technology stocks.

10 iun. 2026, 23:51 UTC

Social Media

CSX shares advance in after-market trading, driven by recognition of the Howard Street Tunnel Project by RTS Magazine as a top 2026 project.

10 iun. 2026, 23:51 UTC

Fastenal shares are higher in after-market trading, supported by a rise in the Trading Companies & Distributors sub-sector. The stock remains above its 20-day moving average.

10 iun. 2026, 23:51 UTC

Global equity markets decline amid U.S.-Iran tensions and mixed economic data, as inflation concerns rise ahead of key Federal Reserve decisions.

10 iun. 2026, 23:51 UTC

Asia equity markets decline amid U.S.-Iran tensions and mixed economic signals from China, while investors brace for U.S. inflation data impacting Federal Reserve policy.

10 iun. 2026, 23:51 UTC

European equity markets decline amid U.S.-Iran tensions and weak UK housing data, while investors await ECB rate hike and U.S. inflation figures.

10 iun. 2026, 23:51 UTC

US equity markets decline amid rising geopolitical tensions with Iran and persistent inflation concerns ahead of key economic data.

10 iun. 2026, 23:51 UTC

UK House Price Balance Data Shows Deeper Decline at -0.35%, Heightening Economic Concerns Amid Global Uncertainties

10 iun. 2026, 23:51 UTC

South Korea's unemployment rate holds steady at 2.8% amid job losses and global economic uncertainties, raising concerns for investor confidence.

10 iun. 2026, 23:51 UTC

Brazil's Inflation Rate Expected to Rise to 4.66% YoY in May Amid Global Price Pressures and Geopolitical Tensions

10 iun. 2026, 23:51 UTC

Brazil's Business Confidence Index set for June 12 release shows cautious market sentiment amid ongoing economic uncertainties.

10 iun. 2026, 23:51 UTC

Check Point Software Technologies is lower in after-market hours amid broader market weakness and declines in the Systems Software sector. No specific company news was identified.

10 iun. 2026, 23:51 UTC

News

ETF Constituents

The Vanguard Growth ETF is lower in after-market hours, impacted by declines in major holdings like Amazon and AMD amid broader geopolitical tensions.

10 iun. 2026, 23:51 UTC

abrdn Physical Palladium Shares ETF is lower in after-market trading amid declining global equity markets due to rising tensions between the U.S. and Iran.

10 iun. 2026, 23:51 UTC

Intuitive Surgical Inc shares are lower in after-market trading amid broader market declines and no specific company news identified. Concerns over geopolitical issues persist.

10 iun. 2026, 23:51 UTC

American Airlines Group Inc shares are lower in after-market hours, reflecting broader market weakness amid rising bond yields and recent economic data.

10 iun. 2026, 23:51 UTC

Correlated Moves

Applied Materials Inc shares are lower in after-market hours, reflecting broader market declines and notable drops in major technology stocks amid geopolitical concerns.

10 iun. 2026, 23:51 UTC

Correlated Moves

Alphabet Inc. shares are lower in after-market trading, reflecting broader market weakness amid geopolitical concerns and profit-taking in major tech stocks.

10 iun. 2026, 23:46 UTC

Take-Two Interactive Software Inc shares are lower in after-market hours, continuing a trend of declining performance without any specific news to explain the movement.

10 iun. 2026, 23:46 UTC

Workday Inc. shares are lower in after-market trading, continuing a trend of five consecutive sessions of declines amid no specific news to explain the movement.

10 iun. 2026, 23:46 UTC

News

Starbucks Corp reported strong Q2 results and positive FY26 guidance. Shares are modestly higher in after-market trading, recovering from an earlier dip.

Comparație

Modificare preț

Genmab A-S Așteptări

Obiectiv de preț

By TipRanks

-1.49% jos

Prognoză pe 12 luni

Medie 2,493.35 DKK -1.49%

Maxim 3,320 DKK

Minim 308.417 DKK

În baza a 7 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruGenmab A-S - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

7 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 7 analiști care au acordat evaluări ale acțiunilor Genmab A-S - Dist în ultimele 3 luni.

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Genmab A-S

Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; and Amivantamab for advanced or metastatic gastric or esophageal cancer and NSCLC. Its products include daratumumab to treat MM, non-MM blood cancers, and AL amyloidosis; GEN1047; tisotumab vedotin for treating cervical, ovarian, and solid cancers; DuoBody-PD-L1x4-1BB, and DuoBody-CD40x4-1BB for treating solid tumors; Epcoritamab for relapsed/refractory diffuse large B-cell lymphoma and chronic lymphocytic leukemia; and HexaBody-CD38 and GEN3017 for treating hematological malignancies. In addition, the company develops Inclacumab, which is in Phase 3 trial for vaso-occlusive crises; Camidanlumab tesirine to treat hodgkin lymphoma and solid tumors; JNJ-64007957 and JNJ-64407564 to treat MM; PRV-015 for treating celiac disease; Mim8 for treating haemophilia A; and Lu AF82422 for treating multiple system atrophy disease. It operates various active pre-clinical programs. The company has a commercial license and collaboration agreement with Seagen Inc. to co-develop tisotumab vedotin. It also has a collaboration agreement with argenx to discover, develop, and commercialize novel therapeutic antibodies with applications in immunology and oncology; and AbbVie for the development of epcoritamab, as well as collaborations with BioNTech, Janssen, and Novo Nordisk A/S. Genmab A/S was founded in 1999 and is headquartered in Copenhagen, Denmark.